Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates
CYCCCyclacel(CYCC) ZACKS·2024-08-15 06:36

Cyclacel Pharmaceuticals, Inc. (CYCC) came out with a quarterly loss of 0.72pershareversustheZacksConsensusEstimateofalossof0.72 per share versus the Zacks Consensus Estimate of a loss of 0.83. This compares to loss of 6.60pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof13.256.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 13.25%. A quarter ago, it was expected that this company would post a loss of 4.93 per share when it actually produced a loss of $2.27, delivering a surprise of 53.96%.Over the last four quarters, the compa ...